Clarity at the bedside

Evidence-based decision support for gastroenterologists. Built by a board-certified GI specialist. Grounded in the latest guidelines.

Be first to know when we launch. No spam, ever.

Guideline & literature–driven
Updated with latest literature
No AI-generated recommendations
Board-certified GI author

From question to recommendation

Select a module, answer targeted clinical questions, and receive a structured, guideline-based recommendation — complete with references. 9 modules and continuously expanding.

Choose a module
GI Compass
Evidence-based clinical decision support
IBD
IBD: Diagnosis
Structured diagnostic workup — mimic exclusion, probability assessment
IBD Management
Adult UC & Crohn's Disease — evidence-based treatment algorithms
Pediatric IBD
ECCO-ESPGHAN risk stratification, peds-specific dosing
LIVER
Abnormal Liver Tests
Pattern classification, severity stratification, differential diagnosis
Cirrhosis
Baveno VII staging, MELD 3.0, complications

9 modules spanning IBD, hepatology, screening, and acute care — continuously expanding

Answer clinical questions
← Back
Active Luminal UC
Step 1 of 3  ·  Disease Profile
E1 — Proctitis
Rectum only (≤15 cm)
E2 — Left-sided
Up to splenic flexure
E3 — Extensive / Pancolitis
Beyond splenic flexure
MES 1 — Mild
Erythema, decreased vascular pattern
MES 2 — Moderate
Marked erythema, absent vascular pattern
MES 3 — Severe
Spontaneous bleeding, ulceration
Next

Stepped inputs — only the questions that matter for this patient

Get recommendations
← Back
UC Treatment Recommendations
Clinical Profile
Moderate left-sided ulcerative colitis (E2) with MES 2 activity. Prior vedolizumab failure narrows the eligible treatment pool.
Clinical Acuity
Moderate acuity setting. Advanced-therapy options are generally recommended; routine outpatient monitoring is appropriate.
Treatment Plan
Select a treatment to proceed
Infliximab
Ozanimod
Etrasimod
Upadacitinib
Risankizumab
Guselkumab
Alternatives ▾
Why some drugs were excluded ▾
References (1) ▾
Select a drug above →

Structured output with treatment options, exclusions, and full references

Clinical modules

Every question. One reference.

Each module distills the latest society guidelines into a structured clinical pathway — from initial workup through treatment and follow-up. More modules added regularly.

IBD
IBD Diagnostic
Suspected IBD? Walk through a structured workup — from symptoms and labs to endoscopy and histology — and arrive at a clear diagnostic picture.
UC
UC Management
Manage ulcerative colitis across every scenario: mild-to-moderate flares, acute severe colitis, refractory disease, and long-term remission maintenance.
CD
CD Management
Navigate Crohn's disease from outpatient management to inpatient flares. Includes perianal disease, fistula assessment, and remission strategies.
LFT
Abnormal Liver Tests
Elevated LFTs? Systematically narrow the differential across 37 conditions with drug-interaction screening and fibrosis assessment built in.
CLD
Cirrhosis
From initial suspicion through confirmed cirrhosis — staging, variceal management, ascites care, and transplant referral guidance in one workflow.
GIB
GI Bleed & IDA
Risk-stratify upper and lower GI bleeds, optimize pre-endoscopic care, and work up iron deficiency anemia with a step-by-step approach.
HCC
Liver Lesions
Characterize liver lesions with guideline-based imaging interpretation and manage post-treatment HCC surveillance with structured follow-up protocols.
CRC
Colorectal Cancer
Screening, surveillance, and hereditary syndrome evaluation. Determine the right test, the right interval, and the right follow-up for every patient.
pIBD
Pediatric IBD
Validated pediatric scoring and age-appropriate treatment pathways for active disease and remission in children and adolescents with IBD.
Why GI Compass

Built different, on purpose

GI Compass exists because clinical decision-making deserves better tools — ones that are transparent, current, and built by someone who uses them.

Clinician-built

Designed and authored by a practicing, board-certified gastroenterologist. Every pathway reflects real clinical reasoning — not abstracted guidelines stripped of context.

Evidence-first

Every recommendation links back to its source guideline. Reference libraries are updated as new evidence emerges from ACG, AGA, AASLD, and landmark trials.

Transparent by design

Every recommendation traces directly to a published guideline. No proprietary scoring, no hidden logic. You can see exactly why a recommendation was made.

Deterministic, not AI

No AI-generated clinical output. Every pathway is a deterministic algorithm — same inputs, same outputs. Reproducible, auditable, and transparent.

Always current

Guidelines change. GI Compass keeps pace — modules are updated with each major society guideline release so you're never referencing outdated recommendations.

Works the way you think

No walls of text. No buried flowcharts. Answer a few targeted questions and get a structured, actionable plan tailored to your patient's specific clinical scenario.

Viyan Udawatta, MD

"I built GI Compass because I wanted a tool that thinks the way I think at the bedside — structured, evidence-based, and honest about what we know and don't know."

Viyan Udawatta, MD

Board-certified Gastroenterologist & Hepatologist

Be the first to know

GI Compass is launching soon on iOS, Android, and web. Join the waitlist.

No spam. Unsubscribe anytime.